This study covers the market dynamics and trends
in major countries that are expected to influence the current market scenario
and future status of the Global Hematocrit Test Market over
the forecast period.
Market
Scenario:
Also known as packed-cell volume (PCV) test,
hematocrit test is used to measure the percentage of Red Blood Cells (RBCs) in
the blood. The major function of the RBCs is to carry blood throughout the
body. The test is usually performed to diagnose various diseases such as
anemia, leukemia, lymphoma, congenital heart disease, and others. The test
determines the elevation in the percentage of normal RBCs which is 38.8%-50% in
men and 34.9%-44.5% in women. The hematocrit test is one of the tests included
under complete blood count (CBC) test.
Cardiovascular diseases, cancer, and kidney
diseases are increasing the economic burden of various developing and developed
nations across the globe. The market for hematocrit test is driven by rising
prevalence of chronic diseases such as cardiovascular diseases, diabetes, and
others along with changing lifestyle, and increasing demand for diagnostic
devices for cardiovascular diseases. However, limited number of trained
personnel has restrained the growth of the market. However, the high cost of
diagnosis and treatment of cardiovascular diseases also restrains the growth of
the market. As per the National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK), the overall prevalence of Chronic Kidney Disease (CKD) in the
general population across the globe is nearly 14%. However, the growth of the
market is restrained by the inaccurate or misleading result of the test and
unawareness about hematocrit test in the diagnosis of the disease.
The
global hematocrit test market is expected to grow at a CAGR of 4.5% during the
forecast period.
Segments
The
global hematocrit test market is segmented on the basis of product, indication,
devices, and end-user.
On the
basis of product, the market is segmented into the analyzer, hematocrit test
meter, and others.
On the
basis of indication, the market is segmented into anemia, leukemia, lymphoma,
congenital heart disease, kidney tumor, and others.
On the
basis of the end-user, the market is segmented into hospitals & clinics,
diagnostic centers, and others.
Regional Analysis of the Global
Hematocrit Test
Market
The
global hematocrit test market consists of four major regions namely, the
Americas, Europe, Asia Pacific and the Middle East & Africa, with the
Americas capturing the largest market share. The growth of the market is
attributed to an increase in the demand for diagnostic procedures, and rising importance
of hematology testing for the diagnosis of various chronic diseases. North
America accounts for the major share in the American hematocrit test market
which is attributed to extensive use of hematocrit test with other diagnostic
tests. According to the Center for the Disease Control and Prevention (CDC), as
of 2012, nearly half of all the adults, 117 million population in the U.S. had
one or more chronic health conditions. One in four adults were diagnosed with
two or more chronic health diseases.
In Europe,
the growth of the market is driven by increasing demand for diagnostic devices
and instrument in hospitals and diagnostic centers. Germany, the U.K, and
France are the major contributors to the growth of the market owing to an
increase in the number of key players engaged in the manufacturing of medical
devices and instruments and rising expenditure in research and development by
these major economies. Additionally, well-developed healthcare sector,
ever-increasing patient population and high healthcare expenditure by the
European nations fuel the market growth.
The Asia
Pacific is expecting the fastest growth in the market due to the flourishing
growth of healthcare industries in developing economies such as India.
Additionally, the ever-increasing prevalence of kidney diseases and
cardiovascular diseases and rising demand for quality devices in the healthcare
sector is expected to lead the use of advanced equipment, which, in turn, may
speed up the market growth in the region. Rising geriatric population with
chronic diseases further creates the economic burden on the developing nations
thereby accelerating the market growth.
The
Middle East & Africa hold the least share in the market. The market in this
regions exhibits steady growth owing to an increase in the demand for the
diagnostic and treatment services. In the Middle East and Africa, the
United Arab Emirates (UAE) hold the largest market share owing to the
availability of diagnostic and treatment services. Africa shows slow growth due
to low technology penetration in developing countries.
Key Players in the Global
Hematocrit Test Market
Some of
the key players in this market are Abbott (U.S.), F. Hoffmann-La Roche Ltd
(Switzerland), Siemens AG (Germany), Beckman Coulter, Inc. (U.S.), Bio-Rad
Laboratories, Inc. (U.S.), Horiba, Ltd. (Japan), Mindray Medical International
Limited (China), Boule Diagnostics AB (Sweden), Nihon Kohden Corporation
(Japan), Sysmex Corporation (Japan), and others.
Browse
Complete 110 Pages Premium Research Report Enabled with 77 Respective Tables
and Figures @ https://www.marketresearchfuture.com/reports/hematocrit-test-market-5553
Detailed
Table of Contents:
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
...Continued
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports
(3R), Continuous-Feed Research (CFR), and Market Research & Consulting
Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
